Beryl Drugs: Regulation 57(5) not applicable for quarter

Beryl Drugs (BSE:BERLDRG) has informed the Compliance Department of the Bombay Stock Exchange (BSE) that Regulation 57(5) is not applicable to the company for the quarter ended March 31, 2025. This regulation pertains to disclosures related to interest, dividend, or principal payments on non-convertible securities. According to the company's statement, no such payments are due during the specified quarter. The announcement, dated April 7, 2025, was signed by Sanjay Sethi, Managing Director of Beryl Drugs, and includes his Director Identification Number (DIN: 00090277). The company's registered office is located in Indore, Madhya Pradesh, India. The BSE code for Beryl Drugs is 524606.